By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447




Company News
AVANIR Pharmaceuticals (AVNR) Announces FDA Acceptance Of IND For AVP-786 For The Adjunctive Treatment Of Major Depressive Disorder 7/21/2014 12:38:42 PM
AVANIR Pharmaceuticals (AVNR) Announces Presentation Of Positive Early Results From Prism II Study 7/16/2014 9:54:16 AM
AVANIR Pharmaceuticals (AVNR) Announces Two Data Presentations Related To Pseudobulbar Affect (PBA) At The Alzheimer's Association International Conference (AAIC) 7/1/2014 9:53:34 AM
AVANIR Pharmaceuticals (AVNR) Announces Three Data Presentations Related To AVP-825 For The Acute Treatment Of Migraine At The American Headache Society Annual Meeting 6/24/2014 7:17:19 AM
AVANIR Pharmaceuticals (AVNR)' Migraine Drug AVP-825 Meets Primary Endpoint in Phase 3 Trial 6/10/2014 6:29:28 AM
AVANIR Pharmaceuticals (AVNR) Announces Multiple Data Presentations Related To Pseudobulbar Affect (PBA) Prevalence And Treatment At Two Conferences In June 5/30/2014 7:13:32 AM
AVANIR Pharmaceuticals (AVNR) To Participate In Two Conferences In June 5/28/2014 7:49:46 AM
AVANIR Pharmaceuticals (AVNR) Announces Completion Of Patient Enrollment In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimer's Disease 5/27/2014 9:58:00 AM
AVANIR Pharmaceuticals (AVNR) Reports Fiscal 2014 Second Quarter Financial And Business Results 5/7/2014 6:22:30 AM
AVANIR Pharmaceuticals (AVNR)To Participate In Two Conferences In May 5/1/2014 3:28:06 PM